Excellere Partners Announces Promotion

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Excellere Partners, a leading Denver-based private equity firm specializing in partnering with entrepreneurs and management teams through recapitalizations and management buyouts, is pleased to announce the promotion of Justin Unertl to Partner.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220818005782/en/

Justin Unertl, Partner (Photo: Business Wire)

Justin Unertl, Partner (Photo: Business Wire)

โ€œFor the past 12 years, Justin has served as an invaluable member of the team through his highly impactful origination efforts, commitment to driving value across the portfolio, and pursuit of continuous improvement manifesting in meaningful enhancements to Excellereโ€™s value creation tools and processes,โ€ said Brad Cornell, Managing Partner at Excellere Partners. โ€œThe Managing Partners are pleased to promote Justin to Partner as he exemplifies the next generation of leaders that we are building at Excellere.โ€

Justin joined Excellere in 2010 and has over 15 years of experience supporting entrepreneurs in private equity investments, operations, and financings in emerging growth companies. Justin has helped lead Excellereโ€™s origination efforts in the healthcare and business services sectors with a focus on behavioral health, cybersecurity and regulatory risk management, human capital management, and outsourced insurance services in addition to partnering with management teams on some of Excellereโ€™s most successful investments. Justin currently serves on the Board of Directors at Biocare, LucidHealth, and Medlogix.

About Excellere Partners

Excellere Partners is a Denver-based private equity firm with $2.3 billion of committed capital across four funds that specializes in partnering with entrepreneurs and management teams through recapitalizations and management buyouts. The Firm employs a proven research-driven, top-down investment strategy, and supports its entrepreneurs and management teams with a proprietary value creation process designed to enhance the corporate and operational infrastructure for scalability and growth. Excellereโ€™s investments are focused on emerging growth companies positioned to benefit from industry consolidation and favorable macro-economic and demographic trends. The Firmโ€™s targeted industry sectors include healthcare, industrial growth, and business services. For more information about Excellere, please visit https://www.excellere.com

Contacts

Excellere Partners

Tracie Kelly, 303-870-2068

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  269.95
-2.73 (-1.00%)
AAPL  291.72
-1.60 (-0.55%)
AMD  465.06
+9.87 (2.17%)
BAC  50.70
-0.61 (-1.19%)
GOOG  388.29
-8.76 (-2.21%)
META  599.29
-10.34 (-1.70%)
MSFT  410.69
-4.43 (-1.07%)
NVDA  221.24
+6.04 (2.81%)
ORCL  193.44
-2.51 (-1.28%)
TSLA  445.73
+17.38 (4.06%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gift this article